Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 428-710-1 | CAS number: 207574-76-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- This skin sensitisation study was performed before the testing guideline of the LLNA test was adopted.
Test material
- Reference substance name:
- -
- EC Number:
- 428-710-1
- EC Name:
- -
- Cas Number:
- 207574-76-3
- Molecular formula:
- C46H68N6O6 / C48H72N6O6 / C50H76N6O6 / C52H80N6O6 / C54H84N6O6
- IUPAC Name:
- Condensation products of m-phenylenebis(methylamine) with condensation products of 4-methyl-m-phenylene diisocyanate with alcohols, C10-14 (even numbered)
- Details on test material:
- - Physical state: solid
- Analytical purity: >99%
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Himalayan spotted
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: RCC ltd, Biotechnology & Animal Breeding Division, Wölferstrasse 4, CH-4414 Füllinsdorf, Switzerland
- Age at delivery: 4 - 6 weeks
- Age at pretest start/beginning of acclimatisation period: 4 - 6 weeks
- Body weight at pretest start: 310 - 363 g (pretest group)
- Body weight at beginning of acclimatisation period: 335 - 406 g (control and test group)
- Housing: Individually in Macrolon type-4 cages with standard softwood bedding ("Lignocel", Schill AG, CH-4132 Muttenz)
- Diet (e.g. ad libitum): Pelleted standard Nafag Ecosan 845 25W4, batch nos. 91/98 and 103/98, guinea pig breeding / maintenance diet ("Nafag", Nähr- und Futtermittel AG, CH-9202 Gossau), ad libitum
- Water (e.g. ad libitum): Community tap water from Füllinsdorf, ad libitum, once weeckly additional supply of ascorbic acid (approx. 1 g/l) via the drinking water was provided
- Acclimatization period: One week for the control and test group under test conditions after health examination. No acclimatisation for the animals of the pretest. Only animals without any visible signs of illness were used for the study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 38 - 70
- Air changes (per hr): 10 - 15
- Photoperiod (hrs dark / hrs light): 12 / 12, music was played during the light period
DISTRIBUTION OF ANIMALS (ALL FEMALE)
Control group: 5
Test group: 10
Intradermal pretest: 1
Epidermal pretest: 2
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- physiological saline
- Remarks:
- 1:1 (v/v) mixture of Freund's Complete Adjuvant
- Concentration / amount:
- without test substance / 0.1 ml
- Day(s)/duration:
- Day 1
- Route:
- intradermal
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 400
- Concentration / amount:
- 1 % test substance in PEG 400 / 0.1 ml
- Day(s)/duration:
- Day 1
- Adequacy of induction:
- highest technically applicable concentration used
- Route:
- intradermal
- Vehicle:
- physiological saline
- Remarks:
- 1:1 emulsion with Freund's Complete Adjuvant
- Concentration / amount:
- 1% test substance / 0.1 ml
- Day(s)/duration:
- Day 1
- Adequacy of induction:
- highest technically applicable concentration used
- Route:
- epicutaneous, occlusive
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 400
- Concentration / amount:
- 50%
- Day(s)/duration:
- Day 8 / 48 h
- Adequacy of induction:
- non-irritant substance, but skin pre-treated with 10% SDS
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 400
- Concentration / amount:
- 50%
- Day(s)/duration:
- Day 22 / 24 h
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 5 control animals
10 test animals - Details on study design:
- RANGE FINDING TESTS: PRETEST
The neck of three guinea pigs was shaved and the animals were pre-treated with four intradermal injections (0.1 ml/site) of a 1:1 (v/v) mixture of Freund's Complete Adjuvant/physiological saline, one week prior to the start of the preliminary investigations.
Intradermal injections: 0.1 ml/site, in the clipped flank of one guinea pig at 1% and 3% of the test article in polyethylene glycol (PEG 400; the test article at 5% was technically not applicable). Dermal reactions assessed 24 h later.
Epidermal applications: conducted with two animals, 4 patches of paper (3 x 3 cm) were saturated with test article (ca. 0.2ml/patch): range 10-50% in PEG 400 and applied to both clipped and shaved flanks of each guinea pig. The patches were covered with aluminum foil and firmly secured by elastic plaster wrapped around the trunk covered by impervious adhesive tape for 24 h. The application sites were depilated with depilatory cream for 3-5 minutes, washed with warm water and dried with a disposable towel. Response assessed 24 and 48 h after bandage removal for erythema and edema.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 4 (3 preparations of interdermal injections, 1 preparation for the topical application)
- Exposure period: 48h for the topical induction application
- Test group: 10 animals
- Control group: 5 animlals
- Exposure: on day 1 three pairs of intradermal injections (0.1 ml/site), day 8 (after clipping and shaving again and preparation of the site with 0.5 ml 10% w/v sodium lauryl sulphate in paraffinum perliquidum) 2 x 4 cm patch of filter paper was saturated with the test article (50% in PEG 400), the amount of the test article was approximately 0.3 g, placed over the injection sites on the skin and covered with aluminum foil and secured with elastic plaster and impervious adhesive tape. The occlusive dressing was left in place for 48 h.
- Site: 6 x 8 cm area of dorsal skin on the scapular region, clipped and shaved
- preparations for intradermal injection:
(1) 0.1 ml 1:1 (v/v) mixture of Freund's Complete Adjuvant with physiological saline.
(2) 0.1 ml of test article, 1% in PEG 400.
(3) 0.1 ml of test article at 1% in a 1:1 (v/v) mixture of Freund's Complete Adjuvant with physiological saline.
- treatment of the control animals: as described above for the intradermal injections and the topical application, but without test article
B. CHALLENGE EXPOSURE
- Day of challenge: 22
- Exposure period: 24h
- Test groups: 1 (10 animals)
- Control group: 5 animals
- Site: 5 x 5 cm area on the left and right flank of each guinea pig, clipped and shaved.
- Concentrations: 50 and 0% of test article in PEG 400 (highest non-irritating concentration and vehicle only on left and right flank, respectively), on 3 x 3 cm filter paper using the same method as for the epidermal application. 21h after removal of the dressing, the applications sites were depilated as described in the epidermal pretest.
- Evaluation (hr after challenge): 24 and 48 for erythema and edema. - Challenge controls:
- There were no dermal reactions seen in any of the control animals.
- Positive control substance(s):
- yes
- Remarks:
- 2-Mercaptobenzothiazole
Results and discussion
- Positive control results:
- Positiv control results were generated in the period from 01.12.1998 to 01.01.1999.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no symptoms of systemic toxicity and no deaths were observed
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no symptoms of systemic toxicity and no deaths were observed
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 10%
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 10%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
Any other information on results incl. tables
Maximum concentration not causing irritating effects in preliminary test: 50 %
Signs of irritation during induction:
The expected and common findings, as erythema, oedema,
necrotizing dermatitis, encrustation and exfoliation of
encrustation was observed.
Evidence of sensitisation of each challenge concentration:
0% of the animals showed sensitization.
Applicant's summary and conclusion
- Interpretation of results:
- other: not sensitising according to REGULATION (EC) 1272/2008
- Conclusions:
- Based on these results and according to the EC criteria for classification and labelling according to GHS/CLP (Regulation (EC) No. 1272/2008), the test item does not have to be classified and has no obligatory labelling requirement as skin sensitising.
- Executive summary:
As no skin sensitisation was induced in a GLP-study acc. to OECD guideline 406, test item is considered as not skin sensitising.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.